Table 4. Baseline to 6-month changes in outcome measures for black and for white women who completed 6-month program.
Black (n=76) | White (n=51) | P-value | |
---|---|---|---|
Adiposity | |||
Weight (kg) | −1.8±3.4 | −3.3±5.2 | 0.255 |
Fat mass (kg) | −1.6±2.7 | −2.5±4.3 | 0.532 |
Truncal fat (%) | −1.3±2.5 | −1.7±3.7 | 0.878 |
Abdominal circumference (cm) | −2.1±4.4 | −4.1±6.2 | 0.066 |
Hip circumference (cm) | −1.5±3.6 | −1.9±5.6 | 0.909 |
Exercise performance | |||
Duration (s) | +47±67 | +50±65 | 0.688 |
Peak VO2 (ml kg−1 min−1) | +1.4±3.2 | +1.7±3.1 | 0.585 |
Insulin sensitivity | |||
HOMA | −0.4±1.1 | −0.4±1.1 | 0.947 |
Lipids (n=70, 42) | |||
Total cholesterol (mg dl−1) | −10±19 | −11±31 | 0.760 |
LDL-cholesterol (mg dl−1) | −6±18 | −7±25 | 0.967 |
HDL-cholesterol (mg dl−1) | −2±8 | −3±12 | 0.946 |
Triglycerides (mg dl−1) | −8±29 | −10±32 | 0.501 |
Abbreviations: HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment for insulin resistance; LDL, low-density lipoprotein; VO2, oxygen consumption.
Lipid measurements reported for subjects not taking HMG-CoA reductase inhibitor (statin) medications. Data are presented as mean values±s.d.